Role of angiogenesis in the response to anticancer therapies

被引:5
作者
Teicher, BA [1 ]
机构
[1] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S1368-7646(98)80215-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most solid tumors develop a vasculature (angiogenesis) as they increase in mass. Elucidation of the process by which blood vessels form in tumors has revealed the existence of both positive and negative regulators produced and secreted by many cell types. Angiogenesis has been identified as a critical process in mass expansion in most solid tumors, and numerous molecules have been described to be antiangiogenic agents. The question of whether antiangiogenic therapy is compatible with cytotoxic anticancer therapy has been addressed in the Lewis lung tumor with TNP-470 and minocycline along with radiation therapy and chemotherapy. Although the antiangiogenic therapy had no effect on the tumor size, administration of TNP-470/minocycline increased drug delivery to the tumor and tumor response to cytotoxic therapy increased implicating a potential role for these agents in the treatment of solid tumors.
引用
收藏
页码:59 / 61
页数:3
相关论文
共 24 条
[1]   Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells [J].
Abedi, H ;
Zachary, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (24) :15442-15451
[2]   A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth [J].
AnandApte, B ;
Bao, L ;
Smith, R ;
Iwata, K ;
Olsen, BR ;
Zetter, B ;
Apte, SS .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1996, 74 (06) :853-862
[3]  
[Anonymous], 1994, RADIAT ONCOL INVEST
[4]  
Dark GG, 1997, CANCER RES, V57, P1829
[5]   Markers of tumor angiogenesis: Clinical applications in prognosis and anti-angiogenic therapy [J].
Fox, SB ;
Harris, AL .
INVESTIGATIONAL NEW DRUGS, 1997, 15 (01) :15-28
[6]   The angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium [J].
Fox, SB ;
Westwood, M ;
Moghaddam, A ;
Comley, M ;
Turley, H ;
Whitehouse, RM ;
Bicknell, R ;
Gatter, KC ;
Harris, AL .
BRITISH JOURNAL OF CANCER, 1996, 73 (03) :275-280
[7]  
Fukumura D, 1997, AM J PATHOL, V151, P679
[8]  
Griffiths L, 1997, CANCER RES, V57, P570
[9]  
HERBST RS, 1997, IN PRESS CANC CHEMOT
[10]  
JAIN R, 1997, IEEE MULTIMEDIA, V4, P1